Update on denosumab in postmenopausal osteoporosis--recent clinical data. [electronic resource]
Producer: 20130502Description: 374-9 p. digitalISSN:- 1563-258X
- Aged
- Alendronate -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Bone Density -- drug effects
- Bone Density Conservation Agents -- adverse effects
- Clinical Trials, Phase III as Topic
- Denosumab
- Diphosphonates -- therapeutic use
- Double-Blind Method
- Drug Substitution
- Female
- Humans
- In Vitro Techniques
- Long-Term Care
- Middle Aged
- Osteoclasts -- drug effects
- Osteoporosis, Postmenopausal -- drug therapy
- Osteoporotic Fractures -- prevention & control
- RANK Ligand -- antagonists & inhibitors
- Radius Fractures -- prevention & control
- Randomized Controlled Trials as Topic
- Wrist Injuries -- prevention & control
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.